Literature DB >> 6780101

Release of vasoactive intestinal peptide in the dumping syndrome.

G R Sagor, M G Bryant, M A Ghatei, R M Kirk, S R Bloom.   

Abstract

To determine the effect of gastric surgery on the plasma vasoactive intestinal peptide (VIP) concentration, 13 patients with gastrectomy and seven controls were given an oral hypertonic load (200 ml 50% glucose solution). Blood was taken at intervals during the test for measurement of VIP and blood glucose concentrations and packed cell volume. At the same time observations were made on the occurrence of dumping symptoms and a record kept of the pulse rate. VIP values in the patients with gastrectomy were significantly increased by glucose ingestion, while these did not alter in controls (p less than 0.001). There was a highly significant correlation between the rate of rise in plasma VIP concentration and the rates of rise in packed cell volume (r = 0.85; p less than 0.001) and blood glucose concentration (r = 0.76; p less than 0.01) in patients with gastrectomy. Changes in packed cell volume and blood glucose values and the occurrence of dumping symptoms during the test were significantly different when postoperative patients were compared with controls (p less than 0.001, p less than 0.005, and p less than 0.001 respectively). Furthermore, when the patients with gastrectomy were divided into those without symptoms and those with dumping after meals the latter group showed a significantly greater rise of VIP (p less than 0.05). Despite the increased plasma VIP concentrations observed during dumping, VIP cannot be taken as the sole factor in the pathogenesis of the dumping syndrome.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6780101      PMCID: PMC1504318          DOI: 10.1136/bmj.282.6263.507

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  12 in total

1.  The dumping syndrome. I. Factors responsible for the symptoms.

Authors:  L P LE QUESNE; M HOBSLEY; B H HAND
Journal:  Br Med J       Date:  1960-01-16

2.  The dumping syndrome. II. Cause of the syndrome and the rationale of its treatment.

Authors:  M HOBSLEY; L P LE QUESNE
Journal:  Br Med J       Date:  1960-01-16

3.  Vasoactive intestinal peptide, the major mediator of the WDHA (pancreatic cholera) syndrome: value of measurement in diagnosis and treatment.

Authors:  S R Bloom
Journal:  Am J Dig Dis       Date:  1978-04

4.  5-hydroxyindoles and kinins in the carcinoid and dumping syndromes.

Authors:  I J Zeitlin; A N Smith
Journal:  Lancet       Date:  1966-11-05       Impact factor: 79.321

5.  Vasoactive intestinal peptide and watery-diarrhoea syndrome.

Authors:  S R Bloom; J M Polak; A G Pearse
Journal:  Lancet       Date:  1973-07-07       Impact factor: 79.321

6.  Enzymic iodination of the histidyl residue of secretin: a radioimmunoassay of the hormone.

Authors:  K N Holohan; R F Murphy; R W Flanagan; K D Buchanan; D T Elmore
Journal:  Biochim Biophys Acta       Date:  1973-09-21

7.  Measurement of fasting and postprandial plasma VIP in man.

Authors:  S J Mitchell; S R Bloom
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

8.  Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance.

Authors:  M G Bryant; M M Polak; I Modlin; S R Bloom; R H Albuquerque; A G Pearse
Journal:  Lancet       Date:  1976-05-08       Impact factor: 79.321

9.  ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY.

Authors:  T L GOODFRIEND; L LEVINE; G D FASMAN
Journal:  Science       Date:  1964-06-12       Impact factor: 47.728

10.  Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.

Authors:  S Domschke; W Domschke; S R Bloom; P Mitznegg; S J Mitchell; G Lux; U Strunz
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

View more
  12 in total

Review 1.  Dumping Syndrome: A Review of the Current Concepts of Pathophysiology, Diagnosis, and Treatment.

Authors:  Patrick Berg; Richard McCallum
Journal:  Dig Dis Sci       Date:  2015-09-22       Impact factor: 3.199

2.  A possible role of GLP-1 in the pathophysiology of early dumping syndrome.

Authors:  Hiroshi Yamamoto; Tsuyoshi Mori; Hiroshi Tsuchihashi; Hiroya Akabori; Hiroyuki Naito; Tohru Tani
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

3.  Decreased activity of atrial natriuretic peptide in dumping syndrome after gastric surgery.

Authors:  Z Tulassay; T Tulassay; R Gupta; W Rascher
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

4.  Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty.

Authors:  J M Kellum; J F Kuemmerle; T M O'Dorisio; P Rayford; D Martin; K Engle; L Wolf; H J Sugerman
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

5.  Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995.

Authors:  W P Hopman; R G Wolberink; C B Lamers; J H Van Tongeren
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

6.  Sympathoadrenal activation and the dumping syndrome after gastric surgery.

Authors:  D J Mehagnoul-Schipper; J W Lenders; J J Willemsen; W P Hopman
Journal:  Clin Auton Res       Date:  2000-10       Impact factor: 4.435

7.  Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome.

Authors:  R J Geer; W O Richards; T M O'Dorisio; E O Woltering; S Williams; D Rice; N N Abumrad
Journal:  Ann Surg       Date:  1990-12       Impact factor: 12.969

8.  Plasma peptide YY (PYY) in dumping syndrome.

Authors:  T E Adrian; R G Long; H S Fuessl; S R Bloom
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

9.  Gastric emptying after surgery for the dumping syndrome.

Authors:  A D Harries; M J Dew; E O Crawley; K G Leach; J R Salaman; J Rhodes
Journal:  Postgrad Med J       Date:  1984-07       Impact factor: 2.401

10.  Somatostatin and the dumping syndrome.

Authors:  R G Long; T E Adrian; S R Bloom
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.